# Catalent Maryland, Inc. – FDA Inspection, Apr 9, 2025

Source: https://www.keypedia.com/records/fda_inspections/catalent-maryland-inc/6a5adb56-4aae-4fb8-a5f2-0be2f8c58d24
Source feed: FDA_Inspections

> FDA inspection 1256114 of Catalent Maryland, Inc., April 09, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256114
- Company Name: Catalent Maryland, Inc.
- Inspection Date: 2025-04-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Baltimore District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1206063 - 2023-02-24
- FDA Inspection 1112131 - 2019-11-04

## Related Officers

- [FDA Personnel](https://www.keypedia.com/people/lizaida-perez/686fbdca-bfd7-4a73-990a-d8a97e6b88b7)

Company: https://www.keypedia.com/companies/catalent-maryland-inc/b2f722ce-b6bd-42e6-b648-cec5c4b5f44d

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa
